# Merger-Acquisition-Case
1.  Conducted detailed analysis of acquisition rationale, target firms, and shareholding patterns in the Pharma sector
2.  Evaluated synergies, potential limitations, and performed DCF and relative valuation for strategic insights
3.  Assessed financial impact through EPS accretive/dilutive analysis and sensitivity checks for decision-making
